Gene Expression Profile by Blocking the SYT-SSX Fusion Gene in Synovial Sarcoma Cells. Identification of XRCC4 As a Putative SYT-SSX Target Gene

Yuntao Xie,Maria Törnkvist,Yan Aalto,Gunnar Nilsson,Leonard Girnita,Bálint Nagy,Sakari Knuutila,Olle Larsson

DOI: https://doi.org/10.1038/sj.onc.1207153

IF: 8.756

2003-01-01

Oncogene

Abstract:Increasing evidence suggests that the SYT-SSX fusion gene plays an important role in synovial sarcoma development and progression. However, very little is known about the downstream targets of SYT-SSX . In this study, we used antisense oligonucleotides to block the expression of the SYT-SSX fusion gene in synovial sarcoma cells. By comparing SYT-SSX inhibited cells with noninhibited cells, the gene expression profile was analysed using cDNA microarray and established by real-time PCR. Herewith, using a filter containing 1176 cancer-relevant genes, we found that the DNA repair gene XRCC4 and the DNA mismatch repair gene MSH2 were downregulated, whereas the gene encoding for the serine/threonine protein kinase PRK (also known as CNK), and the macrophage inhibitory cytokine MICI (also known as PLAB) were upregulated after the inhibition of SYT-SSX . In comparison, expression of the XRCC4 gene was undergoing the strongest alteration. Consistently, the protein expression of XRCC4 was found to be decreased after SYT-SSX inhibition, whereas there were no detectable changes for the other gene products. Our study provides some clues to elucidate the signaling pathways of the SYT-SSX fusion gene, as well as it demonstrates a valuable model system for search for other SYT-SSX targets.